Abstract: 12345Disclosed is a compound of formula (I) wherein R R R R R and m are as described herein as a modulator of nicotinic acetylcholine receptors particularly a7 subtype its tautomeric forms its stereoisomers its pharmaceutically acceptable salts its pharmaceutical composition and its combinations with suitable medicaments. Also disclosed are a process of preparation of the compounds and the intended uses thereof in therapy particularly in the prophylaxis and therapy of disorders such as Alzheimer s disease mild cognitive impairment senile dementia and the like.
| # | Name | Date |
|---|---|---|
| 1 | Other Document [13-08-2016(online)].pdf | 2016-08-13 |
| 2 | Form 13 [13-08-2016(online)].pdf | 2016-08-13 |
| 3 | Form 18 [13-10-2016(online)].pdf | 2016-10-13 |
| 4 | PCT IB 304.pdf | 2018-08-11 |
| 5 | GPA of Lupin Limited.pdf | 2018-08-11 |
| 6 | Form-18(Online).pdf | 2018-08-11 |
| 7 | FORM 5.pdf | 2018-08-11 |
| 8 | FORM 3.pdf | 2018-08-11 |
| 9 | FORM 2 & Complete Specification.pdf | 2018-08-11 |
| 10 | ABSTRACT1.jpg | 2018-08-11 |
| 11 | 1484-MUMNP-2015.pdf | 2018-08-11 |
| 12 | 1484-MUMNP-2015-Form 1-230715.pdf | 2018-08-11 |
| 13 | 1484-MUMNP-2015-Correspondence-230715.pdf | 2018-08-11 |
| 14 | 1484-MUMNP-2015-FER.pdf | 2018-10-03 |
| 15 | 1484-MUMNP-2015-AbandonedLetter.pdf | 2019-06-12 |
| 1 | Searchstrategy_1484mumnp2015_28-09-2018.pdf |